Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.

Gordon, Andrew C; Gradishar, William J; Kaklamani, Virginia G; Thuluvath, Avesh J; Ryu, Robert K; Sato, Kent T; Gates, Vanessa L; Salem, Riad; Lewandowski, Robert J

Gordon, Andrew C; Gradishar, William J; Kaklamani, Virginia G; Thuluvath, Avesh J; Ryu, Robert K; Sato, Kent T; Gates, Vanessa L; Salem, Riad; Lewandowski, Robert J.

Afiliação

Gordon AC; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago; Department of Biomedical Engineering, Northwestern University, Evanston, Illinois.
Gradishar WJ; Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago.
Kaklamani VG; Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago.
Thuluvath AJ; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago.
Ryu RK; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago.
Sato KT; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago.
Gates VL; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago.
Salem R; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago; Department of Medicine-Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago; Department of Surgery-Organ Transplantation, Northwestern Universit
Lewandowski RJ; Department of Radiology and Section of Interventional Radiology, Northwestern University Feinberg School of Medicine, Chicago. Electronic address: r-lewandowski@northwestern.edu.

J Vasc Interv Radiol ; 25(10): 1523-32, 1532.e1-2, 2014 Oct.

Article em En | MEDLINE | ID: mdl-25156827

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias da Mama/patologia; Embolização Terapêutica/métodos; Neoplasias Hepáticas/radioterapia; Neoplasias Hepáticas/secundário; Compostos Radiofarmacêuticos/uso terapêutico; Radioisótopos de Ítrio/uso terapêutico; Adulto; Idoso; Idoso de 80 Anos ou mais; Neoplasias da Mama/mortalidade; Progressão da Doença; Embolização Terapêutica/efeitos adversos; Embolização Terapêutica/mortalidade; Feminino; Humanos; Estimativa de Kaplan-Meier; Neoplasias Hepáticas/tratamento farmacológico; Neoplasias Hepáticas/mortalidade; Pessoa de Meia-Idade; Análise Multivariada; Modelos de Riscos Proporcionais; Compostos Radiofarmacêuticos/efeitos adversos; Estudos Retrospectivos; Fatores de Risco; Fatores de Tempo; Falha de Tratamento; Radioisótopos de Ítrio/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Radioisótopos de Ítrio / Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Compostos Radiofarmacêuticos / Embolização Terapêutica / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google